John D. Gerace

John joined NanoString as the chief commercial officer in January 2022.

Before joining NanoString, John served as president of DiaSorin Molecular, LLC, the global molecular diagnostics business unit of DiaSorin SpA. Before DiaSorin, John was president and co-founder of Calabri Biosciences LLC, a consulting firm managing a portfolio of mobile healthcare diagnostics and monitoring assets. Prior to that role, he served as president and CEO of Freedom Meditech, an early commercial-stage medical device company that he staged and sold to Trividia Health, a subsidiary of SinoCare, Inc.

John holds BS degrees in Chemistry and Biological Sciences from the University of California at Irvine with honors and an MBA from Pepperdine University. He currently serves on the Board of Directors for the Lacocca Family Foundation, The UC Irvine Foundation, and University Lab Partners.